Affiliation: Southern Illinois University
- Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trialKrishna J Rocha-Singh
Prairie Education and Research Cooperative, St John s Hospital, Springfield, IL, USA
Catheter Cardiovasc Interv 80:1042-51. 2012..We evaluated the safety and effectiveness of the Xpert™ self-expanding nitinol stent (Abbott Vascular, Redwood City, CA) in Rutherford Class 4-6 subjects with infrapopliteal lesions of 4-15 cm in length...
- Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosisKrishna J Rocha-Singh
Prairie Education and Research Cooperative, Springfield, Illinois 62794 9420, USA
Catheter Cardiovasc Interv 78:779-89. 2011..To provide safety and performance goals for prospective single-arm trials of bare metal renal artery stenting in patients with resistant hypertension associated with high grade atherosclerotic renal artery stenosis...
- Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trialKrishna Rocha-Singh
Prairie Vascular Institute, Springfield, Illionis 62719, USA
Catheter Cardiovasc Interv 72:853-62. 2008..The multicenter, single-arm RENAISSANCE trial evaluated outcomes in patients with progressive atherosclerotic renal artery stenosis (ARAS) treated with the Express Renal Premounted Stent System (Boston Scientific, Natick, MA)...
- Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial diseaseKrishna J Rocha-Singh
Prairie Vascular Institute, Springfield, Illinois 62794 9420, USA
Catheter Cardiovasc Interv 69:910-9. 2007..This analysis proposes safety and performance goals for prospective single-arm trials of bare nitinol stents to treat patients with debilitating claudication associated with femoropopliteal (FP) atherosclerotic lesions...
- Percutaneous renal artery intervention for preservation of renal function: strategies for identification of "at-risk" patientsKrishna Rocha-Singh
Prairie Vascular Institute, Springfield, Illinois, USA
Catheter Cardiovasc Interv 68:507-12. 2006
- Glycoprotein IIb-IIIa receptor inhibition with eptifibatide in percutaneous intervention for symptomatic peripheral vascular disease: the circulate pilot trialKrishna J Rocha-Singh
Vascular Medicine Program, Prairie Heart Institute, St John s Hospital, 619 East Mason Street, Suite 4P57, Springfield, IL 62701, USA
Catheter Cardiovasc Interv 66:470-3. 2005..These results demonstrate that adjunctive use of eptifibatide during percutaneous peripheral intervention is safe and supports further studies to establish the potential efficacy of GP IIb-IIIa inhibitors in this setting...
- Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 studyKrishna Rocha-Singh
Vascular Medicine Program, Prairie Heart Institute, Springfield, Illinois 62794 9420, USA
J Am Coll Cardiol 46:776-83. 2005..This study sought to define the safety and durability of renal stenting after suboptimal/failed renal artery angioplasty in patients with suspected renovascular hypertension...
- Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosisK J Rocha-Singh
Prairie Heart Institute and Prairie Education and Research Cooperative, Springfield, Illinois, USA
Catheter Cardiovasc Interv 47:167-72. 1999....
- One-year clinical outcomes and relative costs of primary infarct artery stenting versus angioplasty following systemic thrombolysis for acute myocardial infarctionK J Rocha-Singh
Prairie Heart Institute at St John s Hospital, Springfield, Illinois 62794, USA
Catheter Cardiovasc Interv 49:135-41. 2000..These findings have important clinical and economic implications in an increasingly cost-conscious health care environment. Cathet. Cardiovasc. Intervent. 49:135-141, 2000...
- Combined glycoprotein IIb/IIIa receptor inhibition and low-dose fibrinolysis for peripheral arterial thrombosisKrishna J Rocha-Singh
Prairie Heart Institute, St John s Hospital and Prairie Education and Research Cooperative, Department of Cardiology, Southern Illinois University School of Medicine, Springfield, Illinois 62794, USA
Catheter Cardiovasc Interv 55:457-60. 2002..No patient required repeat endovascular or surgical revascularization during mean follow-up of 9.3 months. This promising new thrombolytic strategy for the treatment of peripheral arterial occlusive disease requires further study...
- Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathyKrishna J Rocha-Singh
Prairie Heart Institute at St John s Hospital and Prairie Education and Research Cooperative, Department of Cardiology, Southern Illinois University School of Medicine, Springfield, Illinois 62794, USA
Catheter Cardiovasc Interv 57:135-41. 2002..Renal stent revascularization should be considered a valid therapeutic option for the long-term treatment of ischemic nephropathy...
- Heparin-induced thrombocytopenia with thrombosis after endovascular aneurysm repairRaghu Kolluri
Prairie Vascular Institute, Springfield, Illinois 62702, USA
Vasc Endovascular Surg 43:89-92. 2009..This underscores the importance of considering heparin-induced thrombocytopenia as a potential cause for postendovascular thrombotic complications in the patient who develops thrombocytopenia following this procedure...
- Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trialGary M Ansel
Section of Cardiology, Riverside Methodist Hospital, Columbus, Ohio, USA
Catheter Cardiovasc Interv 67:288-97. 2006..To evaluate the effect of glycoprotein IIb/IIIa inhibition during nitinol stenting, of superficial femoral occlusive disease...
- Hope springs eternal: the unfulfilled promise of femoropopliteal stentingKrishna Rocha-Singh
Catheter Cardiovasc Interv 56:450-1. 2002
- Femoropopliteal subintimal angioplasty and nitinol stenting: a marriage of technique and technology...but will it last?Krishna Rocha-Singh
Catheter Cardiovasc Interv 65:544-6. 2005
- Renal and iliac artery stenting by interventional cardiologists and vascular surgeons: the Foundation to Advance Medical Education (FAME) initiativeDavid R Holmes
Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, Minn 55905, USA
Am Heart J 149:883-7. 2005..Programs such as the FAME initiative will grow in importance as new technologies continue to be introduced into medical practice and the need to train physicians in practice in their use expands...
- Embolic protection and platelet inhibition during renal artery stentingChristopher J Cooper
Cardiovascular Division, University of Toledo, 3000 Arlington Ave, MS 1036, Toledo, OH 43614, USA
Circulation 117:2752-60. 2008..Although atheroembolization can cause renal dysfunction during renal stent procedures, whether adjunctive use of embolic protection devices or glycoprotein IIb/IIIa inhibitors improves renal function is unknown...
- Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial diseasePaul Michael Grossman
University of Michigan Healthcare System, Ann Arbor, MI 48109 0311, USA
Am Heart J 153:874-80. 2007....
- Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trialRobert J Lederman
Division of Cardiology, University of Michigan Health System, Ann Arbor, MI, USA
Lancet 359:2053-8. 2002..We investigated whether one or two doses of intra-arterial rFGF-2 improves exercise capacity in patients with moderate-to-severe intermittent claudication...
- The Barath cutting balloon: battling the sword of DamoclesKrishna Rocha-Singh
Catheter Cardiovasc Interv 56:232-3. 2002
- The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial diseaseJohn Spertus
Mid America Heart Institute of Saint Luke s Hospital and the University of Missouri Kansas City, Kansas City, MO, USA
Am Heart J 147:301-8. 2004..The Peripheral Artery Questionnaire (PAQ) is a 20-item questionnaire developed to meet this need by quantifying patients' physical limitations, symptoms, social function, treatment satisfaction, and quality of life...
- Aortorenal artery translesion pressure gradients in renovascular hypertension: In search of clinical significanceKrishna Rocha-Singh
Catheter Cardiovasc Interv 59:378-9. 2003